Viewing Study NCT05409261


Ignite Creation Date: 2025-12-24 @ 12:36 PM
Ignite Modification Date: 2026-01-03 @ 10:21 PM
Study NCT ID: NCT05409261
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-03-27
First Post: 2022-04-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of the Immunogenicity and Safety of Ad26.COV2.S's COVID-19 Vaccine
Sponsor: ANRS, Emerging Infectious Diseases
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-06-02
Start Date Type: ACTUAL
Primary Completion Date: 2022-09-25
Primary Completion Date Type: ACTUAL
Completion Date: 2025-03
Completion Date Type: ESTIMATED
First Submit Date: 2022-04-01
First Submit QC Date: None
Study First Post Date: 2022-06-08
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-03-26
Last Update Post Date: 2024-03-27
Last Update Post Date Type: ACTUAL